The Glittre Activities of Daily Living Test in Chronic Low Back Pain

July 8, 2025 updated by: Merve Firat, Kirsehir Ahi Evran Universitesi

Validity and Reliability of the Glittre Activities of Daily Living Test for Assessing Functional Status in Individuals With Chronic Low Back Pain

The aim of our study is to investigate the validity and reliability of the Glittre activities of daily living test in individuals with chronic low back pain.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

42

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kirsehir, Turkey
        • Kirşehir Ahi Evran University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Individuals with chronic low back pain who are being followed up at the Department of Physical Medicine and Rehabilitation at Kirsehir Ahi Evran University will be included in the study.

Description

Inclusion Criteria:

  • Diagnosed with chronic low back pain
  • Chronic low back pain for at least the last 3 months
  • Being aged 18-65
  • Voluntary participation in the study

Exclusion Criteria:

  • Having orthopedic or neurological impairments
  • History of surgery due to chronic low back pain in the last 6 months
  • Being pregnant
  • Participating in regular physical activity in the past 3 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Indıviduals with chronic low back pain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Daily living activities
Time Frame: 20 minutes
It will be evaluated with the Glittre activities of daily living test
20 minutes
Exercise capacity
Time Frame: 10 minutes
It will be evaluated with 6 minute walk test.
10 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Musle function
Time Frame: 1 minute
It will be assessed with a one-minute sit-stand test.
1 minute
Functional mobility
Time Frame: 1 minute
This will be evaluated with a timed up and go test.
1 minute
Disability level
Time Frame: 5 minutes
It will be assessed with Oswestry Disability Index. High scores on the scale indicate the presence and severity of symptoms.
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Merve Firat, Kirşehir Ahi Evran University
  • Study Chair: Basak Kavalci Kol, Kirşehir Ahi Evran University
  • Study Chair: Figen Tuncay, Kirşehir Ahi Evran University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 5, 2024

Primary Completion (Actual)

May 30, 2025

Study Completion (Actual)

July 8, 2025

Study Registration Dates

First Submitted

November 4, 2024

First Submitted That Met QC Criteria

November 4, 2024

First Posted (Actual)

November 5, 2024

Study Record Updates

Last Update Posted (Actual)

July 9, 2025

Last Update Submitted That Met QC Criteria

July 8, 2025

Last Verified

November 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024-14/121

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe